The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.

One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall exposure in the body over time. The trapezoidal method is commonly employed to calculate this area.

Bioavailability, denoted as F, is another important factor in the noncompartmental approach. It refers to the fraction of an administered dose that reaches the systemic circulation unchanged. Bioavailability can be determined by analyzing drug concentration data, providing insights into the drug's absorption and systemic availability.

The total volume of distribution, represented as Vss, is a parameter that reflects the extent of drug distribution throughout the body. It is calculated by multiplying the drug's clearance by the mean residence time, which refers to the average time a drug molecule spends in the body.

However, calculating the mean residence time using the noncompartmental approach does have one limitation. It can only be readily calculated after a single intravenous (IV) dose. This restriction sets the noncompartmental approach apart from the compartmental approach, which allows more flexibility in estimating pharmacokinetic parameters.

In summary, the noncompartmental approach in pharmacokinetics utilizes clearance, bioavailability, and total volume of distribution to assess the behavior of drugs in the body. It involves calculating the total clearance by dividing the drug dose by the area under the concentration-time curve, determining bioavailability using drug concentration data, and estimating the total volume of distribution by multiplying clearance and mean residence time. However, the noncompartmental approach is limited in calculating mean residence time, as it requires a single dose of IV administration.

来自章节 7:

article

Now Playing

7.29 : Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

Pharmacokinetic Models

7 Views

article

7.1 : 药代动力学数据分析方法:模型和模型非依赖性方法

Pharmacokinetic Models

21 Views

article

7.2 : 药代动力学数据的模型方法:隔室模型

Pharmacokinetic Models

15 Views

article

7.3 : 用于静脉推注给药的单室开放模型:一般注意事项

Pharmacokinetic Models

34 Views

article

7.4 : 用于静脉推注给药的单室开放模型:消除速率常数、半衰期和分布容积的估计

Pharmacokinetic Models

16 Views

article

7.5 : 用于静脉推注给药的单室开放模型:清除率的估计

Pharmacokinetic Models

11 Views

article

7.6 : 单室型号:IV 输注

Pharmacokinetic Models

30 Views

article

7.7 : 用于血管外给药的单室开放模型:零级吸收模型

Pharmacokinetic Models

8 Views

article

7.8 : 用于血管外给药的单室开放模型:一级吸收模型

Pharmacokinetic Models

40 Views

article

7.9 : 单区室开放模型:用于 ka 估计的 Wagner-Nelson 和 Loo Riegelman 方法

Pharmacokinetic Models

47 Views

article

7.10 : 单房室开放模型:尿排泄数据和 k 的测定

Pharmacokinetic Models

15 Views

article

7.11 : 多隔间模型:概述

Pharmacokinetic Models

7 Views

article

7.12 : 双隔室开放式型号:概述

Pharmacokinetic Models

26 Views

article

7.13 : 两室开放模型:IV 推注给药

Pharmacokinetic Models

50 Views

article

7.14 : 两室开放模型:IV 输注

Pharmacokinetic Models

51 Views

See More

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。